Study protocol of the HD-MED study aiming to personalize drug treatment in Huntington's disease: a longitudinal, observational study to assess medication use and efficacy in relation to pharmacogenetics.
Stephanie FeleusMaaike van der LeeJesse Joachim SwenRaymund A C RoosSusanne T de BotPublished in: Therapeutic advances in rare disease (2023)
This study is registered in the International Clinical Trial Registry Platform under registration number NL8251, URL https://trialsearch.who.int/Trial2.aspx?TrialID=NL8251.